Hinge Health (NYSE:HNGE) CEO Daniel Antonio Perez Sells 166,665 Shares

Hinge Health Inc. (NYSE:HNGE) CEO Daniel Antonio Perez sold 166,665 shares of the business’s stock in a transaction on Monday, January 5th. The shares were sold at an average price of $46.38, for a total transaction of $7,729,922.70. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Daniel Antonio Perez also recently made the following trade(s):

• On Monday, December 15th, Daniel Antonio Perez sold 166,670 shares of Hinge Health stock. The stock was sold at an average price of $48.53, for a total transaction of $8,088,495.10.

Hinge Health Price Performance

Hinge Health stock opened at $48.82 on Wednesday. The stock has a market cap of $3.84 billion and a price-to-earnings ratio of -3.72. The firm has a 50-day moving average of $47.14 and a two-hundred day moving average of $49.97. Hinge Health Inc. has a 1 year low of $33.42 and a 1 year high of $62.18.

Hinge Health (NYSE:HNGE) last issued its earnings results on Tuesday, November 4th. The company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.18. The company had revenue of $154.21 million for the quarter, compared to analysts’ expectations of $142.44 million. The firm’s revenue was up 53.3% compared to the same quarter last year.

Hinge Health declared that its board has approved a stock repurchase program on Wednesday, November 12th that permits the company to buyback $250.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 7.2% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s leadership believes its stock is undervalued.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of HNGE. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Hinge Health during the third quarter valued at approximately $37,000. Montag A & Associates Inc. purchased a new stake in shares of Hinge Health during the 2nd quarter valued at $41,000. SBI Securities Co. Ltd. acquired a new stake in shares of Hinge Health in the 2nd quarter worth $48,000. Aster Capital Management DIFC Ltd purchased a new position in Hinge Health during the 3rd quarter worth $49,000. Finally, Jones Financial Companies Lllp increased its position in Hinge Health by 348.0% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock valued at $54,000 after buying an additional 870 shares in the last quarter.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Canaccord Genuity Group raised their price target on Hinge Health from $61.00 to $65.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Evercore ISI raised their target price on shares of Hinge Health from $60.00 to $65.00 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Wall Street Zen lowered shares of Hinge Health from a “buy” rating to a “hold” rating in a report on Sunday, December 28th. Morgan Stanley increased their price objective on shares of Hinge Health from $57.00 to $67.00 and gave the company an “overweight” rating in a research note on Tuesday, September 23rd. Finally, Barclays reduced their price objective on shares of Hinge Health from $65.00 to $60.00 and set an “overweight” rating for the company in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Hinge Health currently has an average rating of “Moderate Buy” and an average price target of $59.60.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.